Biologics manufacturing is a complex process involving living organisms, advanced technologies, and strict quality requirements. Unlike traditional chemical drugs, biologics are produced through biological systems,
A GMP manufacturing facility is designed to ensure that every stage of drug production meets strict quality, safety, and regulatory requirements. From raw material preparation
Drug product manufacturing is a critical stage that transforms a developed pharmaceutical candidate into a stable, safe, and commercially available product. Selecting the right manufacturing strategy
Developing a biopharmaceutical product requires more than successful research results. A process that works at laboratory-scale must also achieve consistent quality, regulatory compliance, and production efficiency
In biopharmaceutical manufacturing, upstream process development determines how efficiently biological systems produce the target product. Among the key factors affecting upstream performance, cell culture optimization
Pharmaceutical formulation development plays a critical role in transforming a drug candidate into a stable, safe, and effective drug product suitable for clinical and commercial use.
Developing a new biopharmaceutical product requires more than identifying a promising molecule. A successful drug candidate must also achieve suitable stability, safety, quality, and manufacturability
Regulatory evaluation for biologics is tightly connected to the clarity and consistency of Chemistry, Manufacturing, and Controls information. For most development programs, the strongest submissions
Microbial expression systems have become an important approach for producing recombinant proteins, peptides, enzymes, plasmids, and other biologics due to their scalability, relatively efficient production
In biopharmaceutical development, scientific innovation is only one part of the journey from discovery to commercialization. A promising molecule must also demonstrate consistent quality, scalable
